Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytoskeletal Proteins | 2 | 2015 | 282 | 0.830 |
Why?
|
| Proteolysis | 3 | 2022 | 195 | 0.810 |
Why?
|
| Drug Discovery | 3 | 2023 | 174 | 0.710 |
Why?
|
| Wilms Tumor | 1 | 2022 | 119 | 0.680 |
Why?
|
| Protein Interaction Maps | 1 | 2021 | 89 | 0.680 |
Why?
|
| Anti-Bacterial Agents | 5 | 2015 | 2553 | 0.660 |
Why?
|
| Bacterial Proteins | 3 | 2015 | 930 | 0.640 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2022 | 571 | 0.610 |
Why?
|
| Leukemia | 1 | 2021 | 373 | 0.560 |
Why?
|
| Kidney Neoplasms | 1 | 2022 | 454 | 0.550 |
Why?
|
| Azithromycin | 2 | 2015 | 43 | 0.500 |
Why?
|
| Staphylococcus aureus | 4 | 2015 | 479 | 0.480 |
Why?
|
| Acrolein | 1 | 2015 | 10 | 0.470 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 3 | 2019 | 87 | 0.440 |
Why?
|
| Drug Design | 1 | 2015 | 161 | 0.430 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 1829 | 0.420 |
Why?
|
| Receptors, Serotonin | 1 | 2013 | 37 | 0.410 |
Why?
|
| Receptors, Dopamine | 1 | 2013 | 32 | 0.410 |
Why?
|
| Drugs, Investigational | 1 | 2013 | 24 | 0.410 |
Why?
|
| Streptococcus pneumoniae | 2 | 2012 | 381 | 0.400 |
Why?
|
| Antiviral Agents | 3 | 2023 | 822 | 0.400 |
Why?
|
| Bacterial Infections | 1 | 2015 | 323 | 0.370 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2015 | 382 | 0.360 |
Why?
|
| Bacteria | 1 | 2015 | 522 | 0.340 |
Why?
|
| Schizophrenia | 1 | 2013 | 332 | 0.330 |
Why?
|
| Antipsychotic Agents | 1 | 2013 | 380 | 0.310 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2021 | 234 | 0.300 |
Why?
|
| Molecular Structure | 4 | 2021 | 322 | 0.270 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 402 | 0.260 |
Why?
|
| Neoplasms | 2 | 2020 | 2953 | 0.240 |
Why?
|
| Transcriptional Elongation Factors | 2 | 2022 | 28 | 0.230 |
Why?
|
| Cell Division | 2 | 2015 | 744 | 0.210 |
Why?
|
| Peptide Hydrolases | 1 | 2023 | 143 | 0.190 |
Why?
|
| Ubiquitination | 2 | 2020 | 174 | 0.190 |
Why?
|
| Gene Expression | 3 | 2022 | 1564 | 0.180 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2022 | 74 | 0.180 |
Why?
|
| Indoles | 1 | 2021 | 201 | 0.160 |
Why?
|
| Virus Replication | 1 | 2023 | 636 | 0.160 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2021 | 827 | 0.160 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2021 | 195 | 0.160 |
Why?
|
| Zika Virus | 1 | 2021 | 151 | 0.160 |
Why?
|
| NFATC Transcription Factors | 1 | 2019 | 38 | 0.150 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2019 | 40 | 0.150 |
Why?
|
| Carcinogenesis | 1 | 2022 | 359 | 0.150 |
Why?
|
| Ligands | 1 | 2020 | 495 | 0.150 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 1158 | 0.150 |
Why?
|
| Triterpenes | 1 | 2018 | 24 | 0.150 |
Why?
|
| Animals | 6 | 2022 | 34953 | 0.130 |
Why?
|
| Humans | 9 | 2023 | 132105 | 0.120 |
Why?
|
| Erythromycin | 2 | 2012 | 21 | 0.120 |
Why?
|
| Staphylococcus | 1 | 2015 | 68 | 0.120 |
Why?
|
| Carbamates | 1 | 2015 | 68 | 0.120 |
Why?
|
| Benzamides | 1 | 2015 | 124 | 0.110 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2013 | 36 | 0.100 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 270 | 0.100 |
Why?
|
| Mice | 4 | 2022 | 18566 | 0.090 |
Why?
|
| Hydrazines | 1 | 2011 | 31 | 0.090 |
Why?
|
| Structure-Activity Relationship | 3 | 2021 | 590 | 0.090 |
Why?
|
| Clarithromycin | 1 | 2011 | 127 | 0.080 |
Why?
|
| Benzimidazoles | 1 | 2011 | 131 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 991 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 1578 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 1396 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 1672 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2019 | 774 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 3698 | 0.040 |
Why?
|
| RNA Helicases | 1 | 2021 | 70 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 143 | 0.040 |
Why?
|
| Oncogenes | 1 | 2021 | 175 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2021 | 189 | 0.040 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2021 | 172 | 0.040 |
Why?
|
| Prognosis | 2 | 2019 | 5008 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 94 | 0.040 |
Why?
|
| Lupus Nephritis | 1 | 2019 | 43 | 0.040 |
Why?
|
| Glomerulonephritis | 1 | 2019 | 74 | 0.040 |
Why?
|
| RING Finger Domains | 1 | 2018 | 2 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2018 | 111 | 0.040 |
Why?
|
| Sjogren's Syndrome | 1 | 2019 | 101 | 0.040 |
Why?
|
| Medical Oncology | 1 | 2019 | 243 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 663 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 273 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2019 | 214 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 281 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 998 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2019 | 1118 | 0.030 |
Why?
|
| Cell Movement | 1 | 2019 | 891 | 0.030 |
Why?
|
| Bacillus subtilis | 1 | 2015 | 50 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2019 | 488 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2019 | 511 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 615 | 0.030 |
Why?
|
| Dementia | 1 | 2019 | 475 | 0.030 |
Why?
|
| Protein Binding | 1 | 2018 | 1735 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 686 | 0.030 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 229 | 0.030 |
Why?
|
| Rats | 1 | 2019 | 3612 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 2453 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1285 | 0.020 |
Why?
|
| Inflammation | 1 | 2019 | 1522 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 922 | 0.020 |
Why?
|
| Methyltransferases | 1 | 2011 | 82 | 0.020 |
Why?
|
| Biomarkers | 1 | 2019 | 3380 | 0.020 |
Why?
|
| Obesity | 1 | 2019 | 2396 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 4694 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 4725 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2011 | 1597 | 0.010 |
Why?
|
| Male | 2 | 2019 | 64918 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 28936 | 0.010 |
Why?
|
| Female | 1 | 2019 | 70680 | 0.010 |
Why?
|